Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Harbour BioMed Announces First Patient Dosed in Phase I Study of First-in-Class Anti-B7H7 (HHLA2) Antibody HBM1020 2023-06-05 09:01
VVN539 met primary study endpoints in US phase IIa clinical study for the treatment of glaucoma 2023-06-05 08:00
Innovent Presents Phase 1b Clinical Data of IBI110 (Anti-LAG-3 Monoclonal Antibody) at the 2023 ASCO Annual Meeting 2023-06-05 08:00
Sanyou launches new European offices and continues to promote global business landscape 2023-06-03 20:05
Innovent Announces the Second Breakthrough Therapy Designation by NMPA for Olverembatinib for the Treatment of Patients with SDH-Deficient GIST 2023-06-03 07:59
Transcenta Holding Limited (6628.HK) to Hold 2023 ASCO Business Update call Conference. 2023-06-02 19:14
Latest Updates of 9 Viva's Portfolio Companies 2023-06-02 18:51
TWi Biotechnology Exploring Promising Treatment for Granuloma Annulare (GA) 2023-06-02 15:51
NMPA accepted Akeso's ebronucimab (PCSK9) marketing application in two cardiovascular indications 2023-06-02 11:43
Innovent Enters into Clinical Trial Collaboration with Merck KGaA, Darmstadt, Germany Investigating Combination Therapy of IBI351 (KRASG12C Inhibitor) and Cetuximab (ERBITUX®)for KRASG12C-mutated NSCLC in China 2023-06-02 08:00
EVERSANA Forms Strategic Alliance with China Resource Pharmaceutical Commercial Group to Bring New Novel Treatments to Patients Globally 2023-06-02 00:10
Sirnaomics Dosed the First Patient in Phase I Clinical Study of GalNAc-Based RNAi Therapeutic STP122G for Anticoagulant Treatment 2023-06-02 00:06
GenEros to Present Promising Results of GEC255 Phase I Clinical Trial for Advanced NSCLC Patients with KRAS G12C Mutation 2023-06-01 22:15
YS Biopharma's PIKA Rabies Vaccine Receives Phase 3 Clinical Trial Approval From Philippines FDA 2023-06-01 20:30
Impact Therapeutics Entered into Global Partnership with Eikon Therapeutics to Develop and Commercialize PARP1 Selective Inhibitors 2023-06-01 20:30
BIORCHESTRA Invited to Present Update on Central Nervous System Lead Program (BMD-001) and IV-Formulated siRNA Data at BIO2023 International Conference 2023-06-01 20:00
Seegene Obtains IVDR Certification for 30 Diagnostic Assays 2023-06-01 19:00
Xinhua Silk Road: Activity to promote TCM cultural exchanges and cooperation between China and Luxembourg completes success 2023-06-01 17:37
Croma-Pharma: Launch of topical anaesthetic Pliaglis® in Europe 2023-06-01 17:18
Antengene Announces XPOVIO® plus Bortezomib and Dexamethasone Included for Reimbursement by the PBS in Australia for the Treatment of Relapsed and/or Refractory Multiple Myeloma 2023-06-01 10:09
1 61 62 63 64 65 375